赛诺菲股票：我如何利用这只被低估的股息贵族 (NASDAQ:SNY)
· seekingalpha.com
赛诺菲的疫苗部门在 2026 年第二季度同比出现 4.7% 的负增长，受到流感和 COVID-19 业务的拖累。了解为什么 SNY 股票值得买入。
Sanofi ( SNY ) has been punished by the market due to multiple pipeline failures recently. That’s very important, indeed, because these pipeline candidates sh...